Abstract
The aim was to determine whether high glucose levels interfere with nitric oxide (NO) production and inducible NO synthase (iNOS) protein expression in interleukin-1beta-stimulated vascular smooth muscle cells from normotensive Wistar Kyoto and spontaneously hypertensive rats. Cells were incubated with either normal (5.5 mM) or high (22 mM) d-glucose for 72 h and with interleukin-1beta (10 ng/ml) for the last 24 h. High glucose increased nitrite levels, iNOS expression and protein kinase C activity in cells from normotensive rats and had no effect in cells from hypertensive rats. High glucose effects on nitrite production and iNOS expression was abolished by the selective inhibitor for the protein kinase C-betaII, 5,21:12,17-dimetheno-18H-dibenzo[i,o]pyrrolo[3,4-1] [1,8]diacyclohexadecine-18,20 (19H)-dione, 8-[(dimethylamino) methyl]-6,7,8,9,10,11-hexahydro-monomethanesulfonate (LY379196, 30 nM). Calphostin C (1 microM) and LY379196 (10 microM) reduced nitrite levels and iNOS expression only in cells from normotensive rats treated with both media. These results suggest that high glucose increases inducible nitric oxide synthase induction and subsequent NO production by activating the protein kinase C-betaII; this mechanism seem...Continue Reading
References
Mar 1, 1979·Diabetes Care·W B Kannel, D L McGee
Feb 1, 1991·The Journal of Clinical Investigation·D BeasleyB M Brenner
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·Y AsaokaY Nishizuka
Jan 1, 1991·The Journal of Clinical Investigation·B A WolfJ Turk
Mar 1, 1984·Progress in Cardiovascular Diseases·N B Ruderman, C Haudenschild
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Dec 1, 1995·Hypertension·J R Sowers, M Epstein
Aug 11, 1994·Biochimica Et Biophysica Acta·Y J GengG K Hansson
May 1, 1995·Journal of Hypertension·B Williams
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
May 3, 1996·Science·H IshiiG L King
Dec 24, 1996·Biochemical and Biophysical Research Communications·E Nishio, Y Watanabe
Jan 1, 1995·Clinical and Experimental Pharmacology & Physiology. Supplement·K YasunariT Takeda
Mar 1, 1997·British Journal of Pharmacology·A PaulR Plevin
Feb 7, 1998·Hypertension·R MuniyappaJ R Sowers
Feb 14, 1998·Hypertension·T C ChouY A Ding
Dec 18, 1998·Hypertension·K Hishikawa, T F Lüscher
Apr 2, 1999·Diabetes·K K YerneniR Natarajan
May 20, 1999·Hypertension·M H AldermanS Madhavan
Jul 14, 1999·Life Sciences·R XuJ R Sowers
Oct 8, 1999·Diabetes·L BraimanS R Sampson
Aug 10, 2000·Journal of Hypertension·M E PachecoJ Redondo
Aug 23, 2000·Journal of Hypertension·K MizutaniY Yamori
Sep 19, 2000·British Journal of Pharmacology·A M BrionesM Salaices
Oct 4, 2000·British Journal of Pharmacology·H J HongM H Yen
Dec 5, 2000·Vascular Medicine·M Meier, G L King
Apr 17, 2001·Hypertension·J R SowersE D Frohlich
Jul 7, 2001·Diabetologia·I IdrisR Donnelly
Dec 18, 2001·Nephron·Hyunjin NohHo Yung Lee
Mar 21, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·K J WayG L King
Jun 5, 2003·The Journal of Biological Chemistry·Sean ShawMario B Marrero
Jun 24, 2004·Circulation·Alexei KouroedovFrancesco Cosentino
Sep 17, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Yunpeng DuT S Kern
Jan 25, 2006·British Journal of Pharmacology·Tiina SalonenEeva Moilanen
Citations
Sep 24, 2010·Intensive Care Medicine·B LevyF Meziani
Jul 31, 2009·PloS One·Miaozong WuEric R Blough
Oct 29, 2013·Cell Biochemistry and Biophysics·Lai-chun LuGui-sheng Qian
Mar 20, 2009·Canadian Journal of Physiology and Pharmacology·Fang WangZhengyuan Xia
Aug 31, 2010·Toxicology Letters·Cheng-Yi ChangChun-Jung Chen
Jul 10, 2009·Diabetes·Prabhakara Reddy NagareddyKathleen M MacLeod
Jun 21, 2008·Journal of Pharmacological Sciences·Yuji TakahashiIchiro Wakabayashi
Jan 10, 2013·PloS One·Guiyuan JiZhuoqin Jiang
Apr 24, 2008·Molecular Medicine·Carl Nathan
Dec 4, 2019·Biological & Pharmaceutical Bulletin·Deokbae Park